Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
What is eHealth and why is it relevant to cardiology today? Watch videos and case studies and read the latest science on this hot topic
The ESC is involved in a number of EU funded research projects, often as a dissemination partner. Our role is fundamental to ensure the very latest scientific best practice is shared with as many cardiovascular practitioners, researchers and institutions as possible.
The project will create a translational research platform to facilitate cardiovascular data sharing amongst sixteen leading research centres in the European Union (EU) and Canada. It integrates the most well-established data infrastructures, namely the European Genome-Phenome Archive (EGA), Euro-BioImaging and BBMRI-ERIC, to enhance and standardise data deposition, harmonisation and sharing procedures. It integrates more than 35 Canadian and European cohorts that make up over one million records. These cohorts include -omics (genomics, transcriptomics, metabolomics, just to name a few) cardiac imaging and clinical data.
Once established, researchers will benefit from a consolidated one-stop, data-shop to perform efficient and effective research that results in tailor-made patient treatment and better cardiovascular disease outcomes.
This is a Horizon 2020 funded project (grant agreement No 825903).
All Canadian partners are funded by the Canadian Institutes of Health Research (CIHR) and the Fonds de recherche du Québec - Santé (FRQS).
The project announced its kick off in a press release on 11 December 2018.
Cardioscape II is a two-year project funded by the European Research Area Network on Cardiovascular Diseases (ERA-CVD), through Horizon 2020. It is aimed at surveying the European CVD research landscape by mapping national and international research funding opportunities. The project continues the work of the Cardioscape I, updating the data and adding new functionalities to the website. The outcome of the project will help guide the future direction of CVD research within in Europe. In particular, it will drive funding organisations and policymakers to identify research gaps and priorities, highlight areas where coordination could be improved and encourage synergies and cooperation for future research.
The Cardioscape II website is in progress, however, the Cardioscape I project website is still accessible.
The aim of BigData@Heart is to improve patient outcomes and reduce the societal burden of heart failure, atrial fibrillation and acute coronary syndrome (ACS) in Europe.
BigData@Heart’s ultimate ambition is to unlock the societal, scientific, clinical and industrial value of current and future European data sets by fully realising the potential big data approaches have for cardiovascular diseases.
This is an Innovative Medicines Initiatives (IMI) funded project.
In this project, leading European scientific teams which have created large relevant population cohorts, mostly dedicated to Sudden Cardiac Arrest (SCA) research, join forces to fully exploit available data towards improving SCA management. This will be done by:
This is a Horizon 2020 funded project.
PAPAartis is a phase II trial to demonstrate that a staged treatment approach for Chronic aortic aneurysms can reduce paraplegia and mortality dramatically.
It can be expected to have both a dramatic impact on the individual patient's quality of life if saved from a wheelchair and also upon financial systems through savings in:
Some 2 500 patients a year in Europe undergo these high-risk operations with a cumulative paraplegia rate of over 15%; therefore >€100 million per year in costs can be avoided and significantly more considering the expected elimination of type II endoleaks.
The objective of the BETA 3_LHV project is to prevent patients having a structural heart remodelling, and therefore at risk, to develop a heart failure.
The project is a clinical trial with an already marketed drug, known to be effective in bladder disorders that will be administered to patients in a new indication.
Characterising Atrial by FibrillationTranslating its Causes into Health Modifiers in the Elderly (CATCH ME) brings together the expertise of leading academic institutes, healthcare organisations and professional societies to improve the care of patients with Atrial Fibrillation.
ESC will not participate in projects for endorsement purposes only.
Only projects related to the ESC mission statement and ESC strategic orientations will be considered. This includes, of course, Working Groups, Councils and Associations.
The final decision will be taken by ESC leadership.
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved